Filing Details
- Accession Number:
- 0001209191-11-042501
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-08-04 17:14:32
- Reporting Period:
- 2011-08-02
- Filing Date:
- 2011-08-04
- Accepted Time:
- 2011-08-04 17:14:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1492426 | Horizon Pharma Inc. | HZNP | Pharmaceutical Preparations (2834) | 272179987 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1398598 | Hubert Birner | C/O Horizon Pharma, Inc. 1033 Skokie Blvd., Suite 355 Northbrook IL 60062 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-08-02 | 113,361 | $0.00 | 113,361 | No | 4 | C | Indirect | See FN |
Common Stock | Acquisiton | 2011-08-02 | 20,646 | $0.00 | 134,277 | No | 4 | C | Indirect | See FN |
Common Stock | Acquisiton | 2011-08-02 | 27,371 | $9.00 | 161,648 | No | 4 | C | Indirect | See FN |
Common Stock | Acquisiton | 2011-08-02 | 33,882 | $9.00 | 195,530 | No | 4 | P | Indirect | See FN |
Common Stock | Acquisiton | 2011-08-02 | 409,116 | $0.00 | 409,116 | No | 4 | C | Indirect | See FN |
Common Stock | Acquisiton | 2011-08-02 | 74,511 | $0.00 | 483,627 | No | 4 | C | Indirect | See FN |
Common Stock | Acquisiton | 2011-08-02 | 98,784 | $9.00 | 582,411 | No | 4 | C | Indirect | See FN |
Common Stock | Acquisiton | 2011-08-02 | 122,280 | $9.00 | 704,691 | No | 4 | P | Indirect | See FN |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | See FN |
No | 4 | C | Indirect | See FN |
No | 4 | C | Indirect | See FN |
No | 4 | P | Indirect | See FN |
No | 4 | C | Indirect | See FN |
No | 4 | C | Indirect | See FN |
No | 4 | C | Indirect | See FN |
No | 4 | P | Indirect | See FN |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Convertible Preferred Stock | Disposition | 2011-08-02 | 401,927 | $0.00 | 401,927 | $0.00 |
Common Stock | Series A Convertible Preferred Stock | Disposition | 2011-08-02 | 555,956 | $0.00 | 555,956 | $0.00 |
Common Stock | Series B Convertible Preferred Stock | Disposition | 2011-08-02 | 44,364 | $0.00 | 44,364 | $0.00 |
Common Stock | Series B Convertible Preferred Stock | Disposition | 2011-08-02 | 61,366 | $0.00 | 61,366 | $0.00 |
Common Stock | Convertible Promissory Notes | Disposition | 2011-08-02 | 0 | $0.00 | 89,652 | $9.00 |
Common Stock | Convertible Promissory Notes | Disposition | 2011-08-02 | 0 | $0.00 | 124,007 | $9.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 210,120 | Indirect | See FN |
Common Stock | 757,347 | Indirect | See FN |
Footnotes
- Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock. Every 2.374 shares of preferred stock converted into one share of common stock upon the closing of the Issuer's initial public offering.
- The securities are held of record by TVM Life Science Ventures VI, L.P. ("TVM VI"). The Reporting Person disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein.
- Represents shares acquired upon conversion, in connection with the Issuer's initial public offering, of convertible promissory notes.
- The securities are held of record by TVM Life Science Ventures VI GmbH & Co. KG ("TVM VI GmbH"). The Reporting Person disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein
- These securities are preferred stock of the Issuer and did not have an expiration date. Prior to the Issuer's initial public offering of common stock, the securities were convertible at any time at the election of the holder. The securities automatically converted into shares of common stock upon the closing of the issuer's initial public offering of common stock.
- Principal and accrued interest converted upon the Issuer's initial public offering of common stock, into shares of common stock.